Initiation of Phase 1b study using SGT-212 for the treatment of patients with Friedreich's Ataxia expected in 2H25. Click ...
TG Therapeutics exceeded 2024 revenue guidance by 24%, signaling strong growth. Read more to see why I rate TGTX stock a ...
The Phase 1 GALLOP study evaluating the investigational therapy, CB-010, for treatment of lupus nephritis has launched.
Beam is pursuing a long-term, staged development strategy for sickle cell disease that includes three “waves” of ...
Cambridge, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing ...
March 2024: Moleac Pte Ltd announced a study of Phase 4 clinical trials for NeuroAiD. SATURN investigates the promising role ...
About Alpha Cognition Inc. Alpha Cognition Inc. is a commercial stage, biopharmaceutical company dedicated to developing treatments for ... in the Company’s Form S-1/A registration statement ...
We investigated whether or not administration of pantoprazole infusion would improve the outcome in ulcer bleeding following successful endoscopic therapy. Methods: In this double-blind ...
Recently, I've leveled up: I seek out med spas in countries where I have lengthy layovers and book minimal-downtime aesthetic treatments. With the right bookings, I've been able to get treatments ...
If you just found out about Generation Alpha, brace yourself for a new crop of kids set to debut on Jan. 1. Generation Beta will start arriving in 2025 — and some experts predict they will be ...